RecallRadar

FDA Device recall Z-1574-2022

Vanta Clinician Programmer Application, Model A71200

On 2022-08-31 the FDA classified a Class II recall of Vanta Clinician Programmer Application, Model A71200 by Medtronic Neuromodulation, citing potential communication issue in which the Vanta Clinician Programmer Application (CP App) A71200 v2.0.2455 may be unable to connect with a Vanta Implantable Neurostimulator (INS)….

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-1574-2022
ClassificationClass II
Statusongoing
Initiated2022-07-26
Published2022-08-31
Last updated2026-09-13 11:56 UTC
CompanyMedtronic Neuromodulation
DistributionAK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, SC, SD, TN, TX, UT, VA, WA, WI, WV, WY

Product

Vanta Clinician Programmer Application, Model A71200. For programming of the Medtronic Model 977006 Vanta implantable neurostimulators for pain therapy.

Reason

Potential communication issue in which the Vanta Clinician Programmer Application (CP App) A71200 v2.0.2455 may be unable to connect with a Vanta Implantable Neurostimulator (INS) Model 977006 when a patient is implanted with more than one neurostimulator.

Identifiers

code_infoModel A71200; Software Version 2.0.2455

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:56 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1574-2022%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.